Clinical Trials
4 trialsNCT04105374 2026-05-07
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma
NRG Oncology
Phase 2/3 Withdrawn
NCT04620278 2026-01-06
Genetic Investigation of Cancer Predisposition
The University of Texas Health Science Center at San Antonio
Not yet recruiting
NCT05148234 2025-09-30
BMS-986253 in Myelodysplastic Syndromes
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT04053114 2025-08-29
MOLTHYSO
Institut Bergonié
Withdrawn